Is ImClone Out of the Woods?
Is ImClone Out of the Woods? If the FDA approves its Erbitux anticancer treatment, as S&P expects, the biotech’s volatile […]
Is ImClone Out of the Woods? If the FDA approves its Erbitux anticancer treatment, as S&P expects, the biotech’s volatile […]
What’s in a Drug Name? Did you ever wonder at the bizarre brand names born by your favorite medicines? If
What’s in a Drug Name? Did you ever wonder at the bizarre brand names born by your favorite medicines? If
Rise in biotech lawsuits Biotech companies were served with 17 percent of all U.S. shareholder suits last year, according to
Agriculture Department looks at revamping biotech rules Worried about the inadvertent spread of new bioengineered plants that produce drugs and
Agriculture Department looks at revamping biotech rules Read Post »
Making Way for Designer Insects The insect world could shortly undergo a genetic makeover in the laboratory. Scientists are at
Biotech firms urge Canada to uphold canola patent Representatives for scientists and biotech firms warned Tuesday that companies could abandon
Biotech firms urge Canada to uphold canola patent Read Post »
Biotech Limits Found Lacking Techniques for limiting the spread of genetically engineered salmon, corn and other organisms are still in
FDA’s economist in chief Foes and friends of Mark McClellan agree on at least one point: The Food and Drug
FDA’s economist in chief Foes and friends of Mark McClellan agree on at least one point: The Food and Drug
Get new actionable insights and updates from BiotechBlog